TOWN:NASDAQTowne Bank Analysis
Data as of 2026-05-05 - not real-time
$35.18
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
TowneBank is trading at $35.18, comfortably above its 20‑day, 50‑day and 200‑day moving averages, indicating short‑term price strength despite a bearish MACD crossover and a neutral RSI of about 51. The stock sits mid‑range between a support level near $34.15 and resistance around $36.80, with volume trending upward, suggesting accumulating interest.
Fundamentally, the bank delivers robust top‑line momentum—revenue grew nearly 30% year‑over‑year—and profitability metrics (operating margin ~36%, profit margin ~19%) are solid. Valuation appears attractive: a trailing P/E of roughly 16 is below the industry average of 17.4, while a forward P/E near 9.8 signals significant upside potential estimated at ~14%. The dividend yield of 3.13% with a payout ratio under 50% looks sustainable, reinforced by a recent one‑time special dividend that may provide a short‑term price boost.
Fundamentally, the bank delivers robust top‑line momentum—revenue grew nearly 30% year‑over‑year—and profitability metrics (operating margin ~36%, profit margin ~19%) are solid. Valuation appears attractive: a trailing P/E of roughly 16 is below the industry average of 17.4, while a forward P/E near 9.8 signals significant upside potential estimated at ~14%. The dividend yield of 3.13% with a payout ratio under 50% looks sustainable, reinforced by a recent one‑time special dividend that may provide a short‑term price boost.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near support with increasing volume
- Bearish MACD histogram indicating near‑term pressure
- Special cash dividend likely to create short‑term buying interest
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth (~30%) and expanding profit margins
- Attractive valuation versus peers (lower P/E, forward P/E <10)
- Sustainable dividend yield of over 3% with moderate payout ratio
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Consistent earnings generation and solid ROE
- Undervalued relative to industry and upside potential
- Stable U.S. operating footprint limiting geographic risk
Key Metrics & Analysis
Financial Health
Revenue Growth29.80%
Profit Margin19.02%
P/E Ratio15.9
ROE6.56%
ROA0.84%
P/B Ratio1.1
Industry P/E17.4
Technical Analysis
TrendNeutral
RSI50.8
Support$34.15
Resistance$36.80
MA 20$35.54
MA 50$34.39
MA 200$34.75
MACDBearish
VolumeIncreasing
Fear & Greed Index90.64
Valuation
Target Price$40.25
Upside/Downside14.41%
GradeUndervalued
TypeBlend
Dividend Yield3.13%
Risk Assessment
Beta0.82
Volatility23.60%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.